Global BCG Vaccine Market by Manufacturers,
Countries, Type and Application, Forecast to
2022
No of Pages – 116
Publishing Date - April 1, 2017
Browse detailed TOC, Tables, Figures, Charts in Global BCG Vaccine Market by
Manufacturers, Countries, Type and Application, Forecast to 2022 at -
http://www.360marketupdates.com/10561680
"BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection,
which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys.
The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely
used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the
national childhood immunization programme.?
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the
growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the
cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive."
Scope of the Report:
This report focuses on the BCG Vaccine in Global market, especially in North America, Europe and
Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on
manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immune BCG